Review assay overview and results for measuring the release of up to three cytokines from T cells.
Guided by T cell expert, Yelena Bronevetsky, PhD, get a deeper look at how the Opto™ Cell Therapy Development workflow can be used to validate, expand, and fully characterize over a 1,000 T cells.
This poster describes in detail how to sequence and clone IDH1 R132H targeted monoclonal T cell receptors from CD4+ T cells, using the Beacon system.
Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.